PF-06410293 (Adalimumab-Pfizer)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-06410293 (Adalimumab-Pfizer), covering 2015-04-13 to 2015-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07)) [Phase 1]